Search

Your search keyword '"Casale, T"' showing total 695 results

Search Constraints

Start Over You searched for: Author "Casale, T" Remove constraint Author: "Casale, T"
695 results on '"Casale, T"'

Search Results

8. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

9. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

10. The ARIA-MeDALL hypothesis

17. Relation between reduction in fractional exhaled nitric oxide and efficacy in asthma patients treated with dupilumab

19. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products

20. Development and validation of combined symptom-medication scores for allergic rhinitis*

21. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model

22. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data

23. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

24. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

25. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

27. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

29. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

30. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

31. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

34. EAACI Biologicals Guidelines—Recommendations for severe asthma

35. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

36. Management of anaphylaxis due to COVID-19 vaccines in the elderly

40. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

41. Efficacy and safety of treatment with dupilumab for severe asthma : A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma

42. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

43. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

44. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

45. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

46. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

47. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma

48. Global implementation of the world health organization's International Classification of Diseases (ICD)-11: The allergic and hypersensitivity conditions model

Catalog

Books, media, physical & digital resources